Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 2
1952 2
1953 1
1954 2
1956 4
1958 2
1959 1
1960 7
1961 10
1962 16
1963 18
1964 10
1965 4
1966 11
1967 15
1968 19
1969 11
1970 17
1971 28
1972 30
1973 27
1974 27
1975 51
1976 36
1977 75
1978 107
1979 122
1980 128
1981 124
1982 137
1983 119
1984 161
1985 158
1986 202
1987 220
1988 241
1989 277
1990 300
1991 319
1992 354
1993 355
1994 399
1995 458
1996 569
1997 565
1998 578
1999 634
2000 713
2001 779
2002 970
2003 1030
2004 1242
2005 1445
2006 1625
2007 1672
2008 1928
2009 2045
2010 2474
2011 2749
2012 3066
2013 3444
2014 3476
2015 3796
2016 3954
2017 4244
2018 4492
2019 4894
2020 5836
2021 6908
2022 7526
2023 7256
2024 2178

Text availability

Article attribute

Article type

Publication date

Search Results

77,445 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Hsiang-Yueh
Page 1
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition.
Jain V, Harper SL, Versace AM, Fingerman D, Brown GS, Bhardwaj M, Crissey MAS, Goldman AR, Ruthel G, Liu Q, Zivkovic A, Stark H, Herlyn M, Gimotty PA, Speicher DW, Amaravadi RK. Jain V, et al. Cancer Discov. 2023 Feb 6;13(2):454-473. doi: 10.1158/2159-8290.CD-22-0535. Cancer Discov. 2023. PMID: 36331284 Free PMC article.
To elucidate LAI resistance, proteomics and immunoblotting demonstrated that LAI induced lipid metabolism enzymes in multiple cancer cell lines. ...Although UGCG inhibition decreased LAI-induced GMM and augmented cell death, UGCG overexpression led to LAI
To elucidate LAI resistance, proteomics and immunoblotting demonstrated that LAI induced lipid metabolism enzymes in multiple …
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Lin D, Thompson-Leduc P, Ghelerter I, Nguyen H, Lafeuille MH, Benson C, Mavros P, Lefebvre P. Lin D, et al. CNS Drugs. 2021 May;35(5):469-481. doi: 10.1007/s40263-021-00815-y. Epub 2021 Apr 28. CNS Drugs. 2021. PMID: 33909272 Free PMC article.
In turn, the clinical benefits achieved may translate into lower economic burden. Real-world evidence of the comparative effectiveness of LAI is needed to understand the potential benefits of LAI outside of the context of clinical trials. ...Comparative studies repo …
In turn, the clinical benefits achieved may translate into lower economic burden. Real-world evidence of the comparative effectiveness of …
[LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN SCHIZOPHRENIA].
Teitelbaum A, Kodesh A. Teitelbaum A, et al. Harefuah. 2019 Jul;158(7):453-457. Harefuah. 2019. PMID: 31339245 Review. Hebrew.
Several studies comparing LAI AP with oral antipsychotics in schizophrenia have been performed, in which RCTs (considered to be the 'gold standard' for clinical trial design) generally show no benefit for LAI AP over oral drugs, whereas observational studies do. The …
Several studies comparing LAI AP with oral antipsychotics in schizophrenia have been performed, in which RCTs (considered to be the ' …
Aripiprazole Lauroxil: A Review in Schizophrenia.
Frampton JE. Frampton JE. Drugs. 2017 Dec;77(18):2049-2056. doi: 10.1007/s40265-017-0848-4. Drugs. 2017. PMID: 29177572 Review.
Thus, aripiprazole lauroxil LAI extends the treatment regimen options for patients with schizophrenia; as with other LAI formulations of antipsychotic agents, it can be particularly recommended for patients with recurrent relapses related to nonadherence to oral pre …
Thus, aripiprazole lauroxil LAI extends the treatment regimen options for patients with schizophrenia; as with other LAI formu …
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.
Schoretsanitis G, Baumann P, Conca A, Dietmaier O, Giupponi G, Gründer G, Hahn M, Hart X, Havemann-Reinecke U, Hefner G, Kuzin M, Mössner R, Piacentino D, Steimer W, Zernig G, Hiemke C. Schoretsanitis G, et al. Ther Drug Monit. 2021 Feb 1;43(1):79-102. doi: 10.1097/FTD.0000000000000830. Ther Drug Monit. 2021. PMID: 33196621 Review.
Reported data combined with positron emission tomography evidence indicated a trend toward lower concentrations under LAI administration than under oral medications. However, the available evidence is insufficient to recommend LAI-specific therapeutic reference rang …
Reported data combined with positron emission tomography evidence indicated a trend toward lower concentrations under LAI administrat …
Olanzapine Pamoate Use for Schizophrenia: Retrospective Records Based Study from a Tertiary Care Hospital.
Grover S, Singla H, Chakrabarti S, Avasthi A. Grover S, et al. Indian J Psychol Med. 2020 Mar 9;42(2):162-167. doi: 10.4103/IJPSYM.IJPSYM_269_19. eCollection 2020 Mar-Apr. Indian J Psychol Med. 2020. PMID: 32346258 Free PMC article.
BACKGROUND: Little is known from India about the experience of using olanzapine long-acting antipsychotic injectables (LAI). In this background, this study aimed to evaluate the clinical profile of patients suffering from schizophrenia who were prescribed olanzapine LAI
BACKGROUND: Little is known from India about the experience of using olanzapine long-acting antipsychotic injectables (LAI). In this …
Lipid based intramuscular long-acting injectables: Current state of the art.
Wilkinson J, Ajulo D, Tamburrini V, Gall GL, Kimpe K, Holm R, Belton P, Qi S. Wilkinson J, et al. Eur J Pharm Sci. 2022 Nov 1;178:106253. doi: 10.1016/j.ejps.2022.106253. Epub 2022 Jul 3. Eur J Pharm Sci. 2022. PMID: 35793750 Free article. Review.
Long acting injectables (LAI) have received increased research and commercial interest due to their potential for improving treatment effectiveness and adherence for antipsychotic, antiviral and addiction treatments. A range of materials have been used to formulate LAI
Long acting injectables (LAI) have received increased research and commercial interest due to their potential for improving treatment …
Converting oral to long-acting injectable antipsychotics: a guide for the perplexed.
Meyer JM. Meyer JM. CNS Spectr. 2017 Dec;22(S1):14-28. doi: 10.1017/S1092852917000840. CNS Spectr. 2017. PMID: 29350127 Review.
Moreover, numerous meta-analyses of the existing literature indicate superiority of long-acting injectable (LAI) over oral antipsychotics when one adjusts for the greater illness severity and duration among patients in LAI antipsychotic trials. The increasing availa …
Moreover, numerous meta-analyses of the existing literature indicate superiority of long-acting injectable (LAI) over oral antipsycho …
Inspirational chemistry of bioabsorbable long-acting injectables.
Tice T. Tice T. Drug Deliv Transl Res. 2023 Feb;13(2):371-377. doi: 10.1007/s13346-022-01199-2. Epub 2022 Aug 21. Drug Deliv Transl Res. 2023. PMID: 35989401 Free PMC article.
Long-acting injectables (LAIs) have made a tremendous impact on clinical medicine. As evidence, dozens of approved LAI products are on the market. These LAI successes, in a large part, came from the clever chemistry of their materials that control drug delivery perf …
Long-acting injectables (LAIs) have made a tremendous impact on clinical medicine. As evidence, dozens of approved LAI products are o …
Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.
Potkin SG, Preda A. Potkin SG, et al. Expert Opin Pharmacother. 2016;17(3):395-407. doi: 10.1517/14656566.2015.1114100. Expert Opin Pharmacother. 2016. PMID: 26864352 Review.
An extended formulation, aripiprazole 400 mg once-monthly (AOM 400) LAI (AOM LAI), received regulatory approval in the year 2013 for the treatment of schizophrenia. ...AREAS COVERED: This review covers data on the efficacy and tolerability/safety of AOM LAI. …
An extended formulation, aripiprazole 400 mg once-monthly (AOM 400) LAI (AOM LAI), received regulatory approval in the year 20 …
77,445 results
You have reached the last available page of results. Please see the User Guide for more information.